Gabaeron, Inc.

San Francisco, CA

UEI
RVDNEZQNYZN3
CAGE
809D2
Primary NAICS
Not on record
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
1650 Owens St, San Francisco, CA 94158, USA
Website
gabaeron.com

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Develop gabaergic neuron protectors for treating APOE4-related alzheimer's disease R44AG063691 National Institute on Aging (NIH) $4,680,420
Somatostatin (SST)-gabaergic interneuron therapy for alzheimer's disease with APOE4 R44AG060873 National Institute on Aging (NIH) $2,223,090

Quick answers

Is Gabaeron, Inc. registered in SAM.gov?

Yes. Gabaeron, Inc.'s SAM.gov registration is active through July 29, 2027.

What is Gabaeron, Inc.'s most recent federal award?

Gabaeron, Inc.'s most recent federal grant award is Develop gabaergic neuron protectors for treating APOE4-related alzheimer's disease (R44AG063691), from National Institute on Aging (NIH), on May 1, 2019.

On GovTribe

See Gabaeron, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login